Xilio Therapeutics XLO
NASDAQ XLO
$8.47 -0.06 (-0.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Xilio Therapeutics (XLO) Asset Utilization Ratio (2025 - 2026)

Updated

Xilio Therapeutics' (XLO) Asset Utilization Ratio came in at 0.40 for Q2 2026, up 219.4% from 0.13 a year earlier and up 20.0% from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Xilio Therapeutics' Asset Utilization Ratio stood at 0.39, up 303.4% from FY2024.

  • In prior years, Xilio Therapeutics' Asset Utilization Ratio was 0.10 in FY2024.
  • According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.34 (Q1 2026), 0.30 (Q4 2025) and 0.24 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.60
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.47
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.51
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 0.50
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.41
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.62
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Xilio Therapeutics 167.94 Mn -378.15 Mn - 0.38
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 0.38
Jun 30, 2026 0.40
Mar 31, 2026 0.34
Dec 31, 2025 0.30
Sep 30, 2025 0.24
Jun 30, 2025 0.13
Mar 31, 2025 0.11
API Access

Xilio Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=XLO&period=max&api_key=YOUR_API_KEY